Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)

NCT01635790 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

246

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ranibizumab
DRUG: Bevacizumab

Sponsor

Prof. dr. R.O. Schlingemann

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]